8/6, 10:22 AM (Source: TeleTrader)
more TeleTrader news

AstraZeneca signs vaccine deal with Shenzhen Kangtai

AstraZeneca plc announced on Thursday that it signed an agreement to supply its COVID-19 vaccine to Shenzhen Kangtai Biological Products.

According to the terms of the agreement, Kangtai will need to produce at least 100 million doses of the experimental shot AZD1222 by the end of 2020 and double the figure for 2021.

The two companies will also explore the possibility of cooperation on the vaccine candidate in other markets, AstraZeneca wrote.

Breaking the News / MD